Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.07 +5.02%

+$0.05 today

Market cap
$213.79M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 10.47M

Average 5.64M

QSI Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Quantum-Si incorporatedNASDAQ: QSI

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses declines year over year

Q1 FY2026 operating expenses of $24.13M fell 5.7% year over year, ahead of the -13.5% change in trailing-twelve-month operating expenses. Sequentially, it rose 13.7% from the prior quarter. Over 3 fiscal years it compounded at -7.3% a year.

Context

  • Operating expenses amounted to 4044.0% of revenue in FY2025, up 441.2 pp from a year earlier.
  • Operating expenses increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -5.7% holds above the trailing-twelve-month pace of -13.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$24.13M+13.7% QoQ
Last fiscal yearDec 2025
$98.51M-10.6% YoY
LTMMar 2026
$97.04M-13.5% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year-10.6%——
3-year CAGR-7.3%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
98.51M USD
Year-over-year change
-10.6%
4-year CAGR
+0.4%

Operating Expenses vs competitors

How QSI compares with its peers on the latest reported figures

  • QSI's LTM Mar 2026 operating expenses of $97.04M is the 9th highest of the 11 companies compared; the peer median is $177.18M.
  • Its year-over-year change of -13.5% is the 8th highest of 10, against a peer median of +11.1%.
  • Operating expenses amounts to 5239.8% of revenue for QSI, versus a peer median of 274.7%.
QSI Competitors Peer median
Operating Expenses for QSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUTLAutolus Therapeutics plcLTM Mar 2026$254.35M -11.1%+20.4%274.7%
RCKTRocket Pharmaceuticals, Inc.LTM Mar 2026$213.72M -20.2%-1.0%—
ANNXAnnexon, Inc.LTM Mar 2026$203.15M +11.1%+13.5%—
SLDBSolid Biosciences Inc.LTM Mar 2026$195.68M +37.3%+15.7%—
ADCTADC Therapeutics S.A.LTM Mar 2026$190.31M -2.8%-18.0%240.4%
DBVTDBV Technologies S.A.LTM Mar 2026$164.05M +44.9%+13.2%—
ENGNenGene Holdings Inc.LTM Apr 2026$132.21M +50.3%+85.1%—
AURAAura Biosciences, Inc.LTM Mar 2026$118.05M +15.1%+23.2%—
QSIQuantum-Si incorporatedLTM Mar 2026$97.04M -13.5%-7.3%5239.8%
ALTAltimmune, Inc.LTM Mar 2026$81.97M -16.5%+2.5%227697.2%
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$46.78M —+121.2%—
Peer median (excluding QSI) $177.18M+11.1%+14.6%274.7%

Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue001.08M3.06M2.44M
Cost of Revenue00594K1.46M1.28M
Gross Profit00488K1.6M1.15M
Gross Margin——45.1%52.3%47.3%
Research & Development46.58M72.06M67.03M59.64M53.76M
Selling, General & Admin50.33M42.3M44.63M50.54M44.75M
Operating Expenses96.91M123.84M111.66M110.18M98.51M
Depreciation & Amortization1.04M2.58M4.16M4.6M4.45M
EBITDA(93.94M)(111.77M)(91.8M)(96.35M)(96.83M)
EBITDA Margin——-8484.7%-3150.8%-3974.8%
Operating Income(96.91M)(123.84M)(111.17M)(108.58M)(97.36M)
Operating Margin——-10274.6%-3550.6%-3996.7%
Interest Income00008.96M
Interest Expense5K0000
Other Income / Expenses1.92M(8.6M)15.21M7.63M(3.92M)
Income Before Tax(94.99M)(132.44M)(95.96M)(100.95M)(101.28M)
Pre-Tax Margin——-8868.8%-3301.2%-4157.7%
Income Tax Expense00056K58K
Net Income(94.99M)(132.44M)(95.96M)(101.01M)(101.34M)
Net Margin——-8868.8%-3303.0%-4160.1%
EPS (Basic)(1.19)(0.95)(0.68)(0.71)(0.51)
EPS (Diluted)(1.19)(0.95)(0.68)(0.71)(0.51)
Weighted Avg Shares79.58M139.26M141.3M143.2M197.77M
Weighted Avg Shares (Diluted)79.58M139.26M141.3M143.2M197.77M

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.